Talinolol

DRUG4 trials

Sponsors

University Medicine Greifswald, Matthias Schwab, Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

Conditions

Drug BiotransformationGastrointestinal Motility DisorderGenotype-related Drug MetabolismMembrane TransportMorbid Obesity

Phase 1

Absorption of Paracetamol, Talinolol and Amoxicillin After Oral Administration Using Non-caloric and Caloric Water

CompletedNCT01635608

University Medicine GreifswaldGastrointestinal Motility Disorder

Start: 2011-04-30Updated: 2012-07-09

Open Label Study for the Functional Characterization of Drug Metabolism and Transport

CompletedNCT01788254

Matthias SchwabGenotype-related Drug Metabolism

Start: 2012-01-31End: 2015-05-31Updated: 2015-05-27

Repeated Dose Study for the Investigation of Heritability of and Genetic Influences on Drug Pharmacokinetics

CompletedNCT01845194

Institut fuer anwendungsorientierte Forschung und klinische Studien GmbHDrug Biotransformation, Membrane Transport

Start: 2009-12-31End: 2013-10-31Updated: 2014-04-21

Bioavailability of Paracetamol, Amoxicillin and Talinolol Before, Immediately and One Year After Gastric Bypass Operation

CompletedNCT02514941

University Medicine GreifswaldMorbid Obesity

Start: 2007-06-30Updated: 2015-08-04

Related Papers

Inherited and Acquired Determinants of Hepatic CYP3A Activity in Humans

Frontiers in Genetics2020-08-2122 citations

Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters.

2016-11-089 citations